The year 2025 began with the annual J.P. Morgan Healthcare Conference (“JPM”) in San Francisco and a series of spectacular transactions, suggesting increased dynamism in the pharmaceutical M&A market – despite, or perhaps because of, the new U.S. administration under President Trump.
26
Mar